Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, announced Tuesday that it has completed the acquisition of the remaining shares in Breakthrough Diagnostics, Inc. from Amarantus Bioscience Holdings, Inc. (OTC: AMBS).
Read the full article: Todos Medical Completes Acquisition of Breakthrough Diagnostics //
Source: https://www.globenewswire.com/news-release/2020/07/28/2069079/0/en/Todos-Medical-Completes-Acquisition-of-Breakthrough-Diagnostics-Gains-Full-Rights-to-the-Alzheimer-s-Blood-Diagnostic-LymPro-Test-from-Amarantus.html